- Home
- CELC vs MOV Comparison
CELC vs MOV Comparison
Compare CELC & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- MOV
- Stock Information
- Founded
- CELC 2011
- MOV 1961
- Country
- CELC United States
- MOV United States
- Employees
- CELC N/A
- MOV N/A
- Industry
- CELC Medical Specialities
- MOV Consumer Specialties
- Sector
- CELC Health Care
- MOV Consumer Discretionary
- Exchange
- CELC Nasdaq
- MOV Nasdaq
- Market Cap
- CELC 489.7M
- MOV 461.8M
- IPO Year
- CELC 2017
- MOV 1993
- Fundamental
- Price
- CELC $12.86
- MOV $20.66
- Analyst Decision
- CELC Strong Buy
- MOV Strong Buy
- Analyst Count
- CELC 6
- MOV 1
- Target Price
- CELC $29.17
- MOV $41.00
- AVG Volume (30 Days)
- CELC 232.9K
- MOV 178.1K
- Earning Date
- CELC 11-14-2024
- MOV 12-05-2024
- Dividend Yield
- CELC N/A
- MOV 6.96%
- EPS Growth
- CELC N/A
- MOV N/A
- EPS
- CELC N/A
- MOV 1.05
- Revenue
- CELC N/A
- MOV $658,329,000.00
- Revenue This Year
- CELC N/A
- MOV N/A
- Revenue Next Year
- CELC N/A
- MOV $5.01
- P/E Ratio
- CELC N/A
- MOV $19.17
- Revenue Growth
- CELC N/A
- MOV N/A
- 52 Week Low
- CELC $11.51
- MOV $17.86
- 52 Week High
- CELC $22.19
- MOV $31.44
- Technical
- Relative Strength Index (RSI)
- CELC 42.58
- MOV 52.03
- Support Level
- CELC $11.94
- MOV $19.88
- Resistance Level
- CELC $13.14
- MOV $21.43
- Average True Range (ATR)
- CELC 0.51
- MOV 0.76
- MACD
- CELC 0.07
- MOV -0.08
- Stochastic Oscillator
- CELC 58.70
- MOV 31.44
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.